- Home
- TCMD vs LAB Comparison
TCMD vs LAB Comparison
Compare TCMD & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- LAB
- Stock Information
- Founded
- TCMD 1995
- LAB 1999
- Country
- TCMD United States
- LAB United States
- Employees
- TCMD N/A
- LAB N/A
- Industry
- TCMD Medical/Dental Instruments
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- TCMD Health Care
- LAB Industrials
- Exchange
- TCMD Nasdaq
- LAB Nasdaq
- Market Cap
- TCMD 314.0M
- LAB 372.1M
- IPO Year
- TCMD 2016
- LAB 2011
- Fundamental
- Price
- TCMD $9.97
- LAB $1.05
- Analyst Decision
- TCMD Hold
- LAB Buy
- Analyst Count
- TCMD 3
- LAB 2
- Target Price
- TCMD $16.00
- LAB $2.50
- AVG Volume (30 Days)
- TCMD 289.6K
- LAB 1.3M
- Earning Date
- TCMD 08-04-2025
- LAB 07-30-2025
- Dividend Yield
- TCMD N/A
- LAB N/A
- EPS Growth
- TCMD N/A
- LAB N/A
- EPS
- TCMD 0.66
- LAB N/A
- Revenue
- TCMD $293,164,000.00
- LAB $169,687,000.00
- Revenue This Year
- TCMD $7.96
- LAB N/A
- Revenue Next Year
- TCMD $8.53
- LAB $12.18
- P/E Ratio
- TCMD $15.10
- LAB N/A
- Revenue Growth
- TCMD 5.96
- LAB 33.86
- 52 Week Low
- TCMD $8.61
- LAB $0.92
- 52 Week High
- TCMD $21.10
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- TCMD 41.97
- LAB 48.48
- Support Level
- TCMD $9.80
- LAB $1.02
- Resistance Level
- TCMD $10.67
- LAB $1.12
- Average True Range (ATR)
- TCMD 0.34
- LAB 0.07
- MACD
- TCMD 0.09
- LAB 0.00
- Stochastic Oscillator
- TCMD 19.54
- LAB 46.67
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.